Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock.

The relationships between cytokine responses in septic shock are currently poorly understood. Some studies have pointed to a biphasic model, with an initial proinflammatory phase, followed by a reactive, anti-inflammatory response to explain the pathogenesis of the most severe form of sepsis. However, evidence for the coexistence of both responses has been found. In this study, the plasma levels of 17 cytokines and chemokines, in 20 patients with septic shock, 11 patients with systemic inflammatory response syndrome (SIRS), during the first 24 hours following diagnosis, and 10 healthy controls, were analyzed and compared. Patients with septic shock showed increased levels of IL-6, IL-8, MCP-1, MIP-1β, IFN-γ, GM-CSF and IL-10 compared to healthy controls. Patients with SIRS showed higher levels of IL-6, IL-8, MCP-1, MIP-1β, G-CSF and IL-10 than controls. Patients with septic shock showed higher levels of IL-8, GM-CSF, MIP-1β than those with SIRS. The Spearman test demonstrated a positive association between the pro-inflammatory mediators IL-6, IL-8, MCP-1, MIP-1β, IFN-γ, GM-CSF and the immunomodulatory cytokine IL-10 in septic shock. Consequently, correlation studies supported the notion that secretion of pro- and anti-inflammatory mediators in septic shock occurs as a simultaneous immune response program initiated early in the course of the disease, revealing that both types of cytokine play a role from the very beginning of this life-threatening condition.

[1]  J. Cavaillon,et al.  Compensatory anti-inflammatory response syndrome , 2008, Thrombosis and Haemostasis.

[2]  C. Coopersmith,et al.  Characterization and Modulation of the Immunosuppressive Phase of Sepsis , 2010, Infection and Immunity.

[3]  F. Santolaria,et al.  Prognostic value of cytokines in SIRS general medical patients. , 2001, Cytokine.

[4]  J. Vincent,et al.  Sepsis biomarkers: a review , 2010, Critical care.

[5]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. , 2009, Chest.

[6]  Fernando A Bozza,et al.  Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis , 2007, Critical care.

[7]  O. Lesur,et al.  Proven infection-related sepsis induces a differential stress response early after ICU admission , 2010, Critical care.

[8]  A. De La Hera,et al.  Mortality in Patients With Septic Shock Correlates With Anti-Inflammatory But not Proinflammatory Immunomodulatory Molecules , 2011, Journal of intensive care medicine.

[9]  M. Hatano,et al.  Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients. , 2008, The Journal of surgical research.

[10]  Garrett E. Schramm,et al.  Septic shock: A multidisciplinary response team and weekly feedback to clinicians improve the process of care and mortality* , 2011, Critical care medicine.

[11]  Marcin P. Joachimiak,et al.  JColorGrid: software for the visualization of biological measurements , 2006, BMC Bioinformatics.

[12]  C. Bondor,et al.  Multiplex cytokine profiling in patients with sepsis , 2011, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[13]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[14]  A. Matsukawa,et al.  Pathophysiology of sepsis and recent patents on the diagnosis, treatment and prophylaxis for sepsis. , 2009, Recent patents on inflammation & allergy drug discovery.

[15]  J. Cavaillon,et al.  Cytokine Cascade in Sepsis , 2003, Scandinavian journal of infectious diseases.

[16]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[17]  K. Shah,et al.  Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock , 2010, Journal of Inflammation.

[18]  V. Kuchroo,et al.  Effector and Regulatory T‐cell Subsets in Autoimmunity and Tissue Inflammation , 2010, Scandinavian journal of immunology.

[19]  N. Klein,et al.  Interleukin-10 and its role in clinical immunoparalysis following pediatric cardiac surgery* , 2006, Critical care medicine.